Plain-English translation of NCT07770100 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial tests a new approach for people with advanced cancer that has spread to multiple parts of the body. The study combines immunotherapy โ a type of treatment that helps your body's immune system fight cancer โ with stereotactic body radiation therapy (SBRT), which is a highly focused form of radiation that targets specific tumors. Researchers want to know if giving these two treatments together is safe and whether it can help control the cancer better than either treatment alone.
Currently, doctors treat advanced cancer that has spread to many parts of the body by giving immunotherapy alone or other systemic treatments. This trial exists to explore whether adding focused radiation to specific tumors, while continuing immunotherapy, might improve how well the treatment works and whether patients can safely receive both at the same time.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will continue receiving your standard immunotherapy treatment while also receiving focused radiation therapy (SBRT) to 6-10 areas where your cancer has spread. The radiation is given in a highly targeted way to minimize damage to healthy tissue. You will be closely monitored throughout the study with regular check-ins, blood tests, and imaging scans to track how well the treatment is working and to watch for any side effects. The study will help doctors understand whether combining these two approaches is both safe and effective for people with advanced cancer.
AI-generated summary from trial data ยท Nov 17, 2026 ยท Not medical advice
United States